Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
NGS for (Hemato-) Oncology in Belgium: Evaluation of Laboratory Performance and Feasibility of a National External Quality Assessment Program.
Delcourt T, Vanneste K, Soumali MR, Coucke W, Ghislain V, Hebrant A, Van Valckenborgh E, De Keersmaecker SCJ, Roosens NH, Van De Walle P, Van Den Bulcke M, Antoniou A. Delcourt T, et al. Among authors: van valckenborgh e. Cancers (Basel). 2020 Oct 29;12(11):3180. doi: 10.3390/cancers12113180. Cancers (Basel). 2020. PMID: 33138022 Free PMC article.
Precision cancer medicine: What has translated into clinical use in Belgium?
Delnord M, Van Valckenborgh E, Hebrant A, Antoniou A, Van Hoof W, Waeytens A, Van den Bulcke M. Delnord M, et al. Among authors: van valckenborgh e. Semin Cancer Biol. 2022 Sep;84:255-262. doi: 10.1016/j.semcancer.2021.06.010. Epub 2021 Jun 12. Semin Cancer Biol. 2022. PMID: 34129914 Review.
Standardization of Somatic Variant Classifications in Solid and Haematological Tumours by a Two-Level Approach of Biological and Clinical Classes: An Initiative of the Belgian ComPerMed Expert Panel.
Froyen G, Le Mercier M, Lierman E, Vandepoele K, Nollet F, Boone E, Van der Meulen J, Jacobs K, Lambin S, Vander Borght S, Van Valckenborgh E, Antoniou A, Hébrant A. Froyen G, et al. Among authors: van valckenborgh e. Cancers (Basel). 2019 Dec 16;11(12):2030. doi: 10.3390/cancers11122030. Cancers (Basel). 2019. PMID: 31888289 Free PMC article.
PRECISION: the Belgian molecular profiling program of metastatic cancer for clinical decision and treatment assignment.
Thouvenin J, Van Marcke C, Decoster L, Raicevic G, Punie K, Vandenbulcke M, Salgado R, Van Valckenborgh E, Maes B, Joris S, Steichel DV, Vranken K, Jacobs S, Dedeurwaerdere F, Martens G, Devos H, Duhoux FP, Rasschaert M, Pauwels P, Geboes K, Collignon J, Tejpar S, Canon JL, Peeters M, Rutten A, Van de Mooter T, Vermeij J, Schrijvers D, Demey W, Lybaert W, Van Huysse J, Mebis J, Awada A, Claes KBM, Hebrant A, Van der Meulen J, Delafontaine B, Bempt IV, Maetens J, de Hemptinne M, Rottey S, Aftimos P, De Grève J. Thouvenin J, et al. Among authors: van valckenborgh e. ESMO Open. 2022 Aug;7(4):100524. doi: 10.1016/j.esmoop.2022.100524. Epub 2022 Aug 12. ESMO Open. 2022. PMID: 35970014 Free PMC article.
Cancer associated fibroblasts and tumor growth: focus on multiple myeloma.
De Veirman K, Rao L, De Bruyne E, Menu E, Van Valckenborgh E, Van Riet I, Frassanito MA, Di Marzo L, Vacca A, Vanderkerken K. De Veirman K, et al. Among authors: van valckenborgh e, van riet i. Cancers (Basel). 2014 Jun 27;6(3):1363-81. doi: 10.3390/cancers6031363. Cancers (Basel). 2014. PMID: 24978438 Free PMC article.
Bortezomib alone or in combination with the histone deacetylase inhibitor JNJ-26481585: effect on myeloma bone disease in the 5T2MM murine model of myeloma.
Deleu S, Lemaire M, Arts J, Menu E, Van Valckenborgh E, Vande Broek I, De Raeve H, Coulton L, Van Camp B, Croucher P, Vanderkerken K. Deleu S, et al. Among authors: van valckenborgh e, van camp b. Cancer Res. 2009 Jul 1;69(13):5307-11. doi: 10.1158/0008-5472.CAN-08-4472. Epub 2009 Jun 16. Cancer Res. 2009. PMID: 19531653
Myeloid-derived suppressor cells induce multiple myeloma cell survival by activating the AMPK pathway.
De Veirman K, Menu E, Maes K, De Beule N, De Smedt E, Maes A, Vlummens P, Fostier K, Kassambara A, Moreaux J, Van Ginderachter JA, De Bruyne E, Vanderkerken K, Van Valckenborgh E. De Veirman K, et al. Among authors: van valckenborgh e. Cancer Lett. 2019 Feb 1;442:233-241. doi: 10.1016/j.canlet.2018.11.002. Epub 2018 Nov 9. Cancer Lett. 2019. PMID: 30419344
66 results